ZLWT-37
Product Specifications
Target
Others|||Apoptosis|||CDK
Related Pathways
Others|||Cell Cycle/Checkpoint|||Apoptosis
Bioactivity
ZLWT-37 is a potent, orally active inhibitor of CDKs, specifically targeting CDK9 (IC50: 0.002 ?M) and CDK2 (IC50: 0.054 ?M), and is capable of blocking the cell cycle of HCT116 cells in G2/M phase and inducing apoptosis.
Molecular Formula
C26H30ClN5O
Molecular Weight
464
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15091023 1 Vial
Lentiviral human PRKCZ shRNA (UAS) - Lentiviral human PRKCZ shRNA (UAS, iRFP) (100)
Ask
View Details